General Information of Drug (ID: DM6XTZL)

Drug Name
MSC-1 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM6XTZL

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukemia inhibitory factor (LIF) TTGZ5WN LIF_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT03490669) Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug name MSC-1).